Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Supplementation of a novel microbial biopolymer, PGB1, from new Enterobacter sp. BL-2 delays the deterioration of type 2 diabetic mice.

Yeo J, Lee YH, Jeon SM, Jung UJ, Lee MK, Jung YM, Choi MS.

J Microbiol Biotechnol. 2007 Dec;17(12):1983-90.

2.

The anti-diabetic effects of ethanol extract from two variants of Artemisia princeps Pampanini in C57BL/KsJ-db/db mice.

Jung UJ, Baek NI, Chung HG, Bang MH, Yoo JS, Jeong TS, Lee KT, Kang YJ, Lee MK, Kim HJ, Yeo JY, Choi MS.

Food Chem Toxicol. 2007 Oct;45(10):2022-9.

PMID:
17574717
3.

Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice.

Ae Park S, Choi MS, Cho SY, Seo JS, Jung UJ, Kim MJ, Sung MK, Park YB, Lee MK.

Life Sci. 2006 Aug 15;79(12):1207-13.

PMID:
16647724
4.

Effects of the ethanol extract of the roots of Brassica rapa on glucose and lipid metabolism in C57BL/KsJ-db/db mice.

Jung UJ, Baek NI, Chung HG, Bang MH, Jeong TS, Lee KT, Kang YJ, Lee MK, Kim HJ, Yeo J, Choi MS.

Clin Nutr. 2008 Feb;27(1):158-67.

PMID:
17996336
6.

Hypoglycemic and hypolipidemic action of Du-zhong (Eucommia ulmoides Oliver) leaves water extract in C57BL/KsJ-db/db mice.

Park SA, Choi MS, Kim MJ, Jung UJ, Kim HJ, Park KK, Noh HJ, Park HM, Park YB, Lee JS, Lee MK.

J Ethnopharmacol. 2006 Oct 11;107(3):412-7.

PMID:
16684593
7.

Eupatilin, isolated from Artemisia princeps Pampanini, enhances hepatic glucose metabolism and pancreatic beta-cell function in type 2 diabetic mice.

Kang YJ, Jung UJ, Lee MK, Kim HJ, Jeon SM, Park YB, Chung HG, Baek NI, Lee KT, Jeong TS, Choi MS.

Diabetes Res Clin Pract. 2008 Oct;82(1):25-32. doi: 10.1016/j.diabres.2008.06.012.

PMID:
18703253
8.

Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice.

Seo KI, Choi MS, Jung UJ, Kim HJ, Yeo J, Jeon SM, Lee MK.

Mol Nutr Food Res. 2008 Sep;52(9):995-1004. doi: 10.1002/mnfr.200700184.

PMID:
18398869
9.
10.

Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.

Harrity T, Farrelly D, Tieman A, Chu C, Kunselman L, Gu L, Ponticiello R, Cap M, Qu F, Shao C, Wang W, Zhang H, Fenderson W, Chen S, Devasthale P, Jeon Y, Seethala R, Yang WP, Ren J, Zhou M, Ryono D, Biller S, Mookhtiar KA, Wetterau J, Gregg R, Cheng PT, Hariharan N.

Diabetes. 2006 Jan;55(1):240-8.

11.

Effects of the novel oral antidiabetic agent HQL-975 on glucose and lipid metabolism in diabetic db/db mice.

Ishikawa Y, Watanabe K, Takeno H, Tani T.

Arzneimittelforschung. 1998 Mar;48(3):245-50.

PMID:
9553681
12.

Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes.

Diani AR, Sawada G, Wyse B, Murray FT, Khan M.

Am J Physiol Endocrinol Metab. 2004 Jan;286(1):E116-22.

13.

Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.

Yamanaka M, Itakura Y, Tsuchida A, Nakagawa T, Noguchi H, Taiji M.

Diabetes Obes Metab. 2007 Nov;9(6):879-88.

PMID:
17924870
14.
15.

Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects.

Calkin AC, Forbes JM, Smith CM, Lassila M, Cooper ME, Jandeleit-Dahm KA, Allen TJ.

Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1903-9.

16.

Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice.

Jung UJ, Lee MK, Park YB, Jeon SM, Choi MS.

J Pharmacol Exp Ther. 2006 Aug;318(2):476-83.

17.

Potential hypoglycemic effect of an ethanol extract of Gynostemma pentaphyllum in C57BL/KsJ-db/db mice.

Yeo J, Kang YJ, Jeon SM, Jung UJ, Lee MK, Song H, Choi MS.

J Med Food. 2008 Dec;11(4):709-16. doi: 10.1089/jmf.2007.0148.

PMID:
19053864
18.

Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.

Arulmozhi DK, Kurian R, Bodhankar SL, Veeranjaneyulu A.

J Pharm Pharmacol. 2008 Sep;60(9):1167-73. doi: 10.1211/jpp.60.9.0008.

PMID:
18718120
19.

Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes.

Phillips JW, Barringhaus KG, Sanders JM, Yang Z, Chen M, Hesselbacher S, Czarnik AC, Ley K, Nadler J, Sarembock IJ.

Circulation. 2003 Oct 21;108(16):1994-9.

20.

Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet.

Jang SM, Yee ST, Choi J, Choi MS, Do GM, Jeon SM, Yeo J, Kim MJ, Seo KI, Lee MK.

Int Immunopharmacol. 2009 Jan;9(1):113-9. doi: 10.1016/j.intimp.2008.10.013.

PMID:
19013541

Supplemental Content

Support Center